HSBC Holdings
AMPH icon

HSBC Holdings’s Amphastar Pharmaceuticals AMPH Stock Holding History

HSBC Holdings’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-38,017
Closed -$753K – 2920
2026
Q1 		$753K Buy
+38,017
New +$930K ﹤0.01% 2007
2025
Q1 		– Sell
-8,991
Closed -$330K – 3024
2024
Q4 		$330K Buy
8,991
+1,707
+23% +$78.1K ﹤0.01% 2441
2024
Q3 		$355K Buy
7,284
+566
+8% +$24.8K ﹤0.01% 2223
2024
Q2 		$271K Sell
6,718
-711
-10% -$29.5K ﹤0.01% 2356
2024
Q1 		$326K Buy
+7,429
New +$384K ﹤0.01% 2395
2023
Q4 		– Sell
-7,163
Closed -$330K – 2714
2023
Q3 		$330K Buy
+7,163
New +$391K ﹤0.01% 2175
2023
Q1 		– Sell
-10,370
Closed -$289K – 2663
2022
Q4 		$289K Buy
10,370
+2,277
+28% +$66.1K ﹤0.01% 2575
2022
Q3 		$232K Buy
8,093
+505
+7% +$16.5K ﹤0.01% 2550
2022
Q2 		$263K Sell
7,588
-828
-10% -$29.5K ﹤0.01% 2708
2022
Q1 		$308K Buy
+8,416
New +$239K ﹤0.01% 2735
2021
Q4 		– Sell
-21,718
Closed -$420K – 3246
2021
Q3 		$420K Hold
21,718
– – ﹤0.01% 2361
2021
Q2 		$435K Sell
21,718
-1,215
-5% -$22.9K ﹤0.01% 2279
2021
Q1 		$420K Sell
22,933
-1,380
-6% -$25.7K ﹤0.01% 2096
2020
Q4 		$485K Hold
24,313
– – ﹤0.01% 2226
2020
Q3 		$460K Buy
24,313
+716
+3% +$14.4K ﹤0.01% 1993
2020
Q2 		$530K Buy
23,597
+6,265
+36% +$115K ﹤0.01% 1802
2020
Q1 		$255K Buy
17,332
+4,902
+39% +$85.3K ﹤0.01% 2150
2019
Q4 		$240K Sell
12,430
-16,093
-56% -$309K ﹤0.01% 2704
2019
Q3 		$566K Buy
+28,523
New +$594K ﹤0.01% 2259

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

HSBC Holdings's AMPH Position: Q2 2026 in Review

HSBC Holdings sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2026, closing a stake of 38,017 shares — an estimated $753K sold.

HSBC Holdings first reported a position in AMPH in Q3 2019 and held it in 19 quarters. The position peaked at $753K in Q1 2026. 212 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • HSBC Holdings reported no remaining Amphastar Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • HSBC Holdings sold 38,017 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $753K.
  • HSBC Holdings first reported a position in Amphastar Pharmaceuticals in Q3 2019 and held it in 19 quarters.
  • HSBC Holdings's Amphastar Pharmaceuticals position peaked at $753K in Q1 2026.
  • 212 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.